Histogen Operating Income

Histogen (HSTO) currently reports a operating income of $-12M as of September 2023. That compares with $-11M in the prior-year period — down 11.5% year over year. Use the charts on this page to explore Histogen's operating income history and peer comparisons.

Histogen's operating income decreased from $-11M to $-12M — a 11.5% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Histogen reported $-12M in operating income as of September 2023. That compares with $-11M in the prior-year period — down 11.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Histogen, and consider following HSTO for alerts when major investors trade the stock.

Histogen is classified in the Healthcare sector. On operating income, it currently shows $-12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HSTO with unrelated industries.